Difficulty: Medium
Average Score: 78%
Practice
A 5-year-old child, recently diagnosed with ileocecal Burkitt lymphoma; lab investigations reveal: serum uric acid 12 mg/dl, serum sodium, 145 meq/dl; serum potassium, 4.5 meq/dl; serum phosphate 4.4 meq/dl; serum calcium, 8.9 mg/dl; blood urea, 22 mg/dl; serum creatinine, 0.8 mg/dl. Of the following, the MOST effective treatment is
Correct answer
D
Rationale
In the case of a 5-year-old with ileocecal Burkitt lymphoma presenting with elevated serum uric acid levels, the most effective treatment is recombinant urate oxidase (Option D). This enzyme helps convert uric acid to a more soluble form that can be easily excreted by the kidneys, thereby preventing the development of tumor lysis syndrome (TLS), a potentially life-threatening complication caused by the rapid release of intracellular components from dying cancer cells.
Excessive hydration (Option A) could lead to dilutional hyponatremia and worsen the electrolyte imbalances seen in TLS. Sodium bicarbonate (Option B) is used to alkalinize the urine and prevent uric acid crystallization in chronic conditions like gout, not in acute TLS. Xanthine oxidase inhibitors (Option C) like allopurinol are used in chronic management of hyperuricemia but may not be sufficient in the acute setting of TLS.
Educationally, understanding the pathophysiology of TLS and the appropriate management strategies is crucial in pediatric oncology. Recognizing the need for prompt intervention with recombinant urate oxidase in TLS can prevent renal failure, cardiac arrhythmias, and other severe complications associated with this oncologic emergency.
Excessive hydration (Option A) could lead to dilutional hyponatremia and worsen the electrolyte imbalances seen in TLS. Sodium bicarbonate (Option B) is used to alkalinize the urine and prevent uric acid crystallization in chronic conditions like gout, not in acute TLS. Xanthine oxidase inhibitors (Option C) like allopurinol are used in chronic management of hyperuricemia but may not be sufficient in the acute setting of TLS.
Educationally, understanding the pathophysiology of TLS and the appropriate management strategies is crucial in pediatric oncology. Recognizing the need for prompt intervention with recombinant urate oxidase in TLS can prevent renal failure, cardiac arrhythmias, and other severe complications associated with this oncologic emergency.